Relx (LON:REL – Get Rating) has been assigned a GBX 3,225 ($42.30) price target by research analysts at The Goldman Sachs Group in a research note issued on Monday, Borsen Zeitung reports. The Goldman Sachs Group’s price target would suggest a potential upside of 32.50% from the stock’s current price.
REL has been the subject of several other reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Relx in a research report on Tuesday, February 8th. Berenberg Bank lifted their price objective on Relx from GBX 2,300 ($30.16) to GBX 2,330 ($30.56) and gave the stock a “hold” rating in a research report on Friday, February 11th. Barclays restated an “overweight” rating and set a GBX 2,605 ($34.16) price objective on shares of Relx in a research report on Friday, February 11th. UBS Group set a GBX 2,615 ($34.30) price objective on Relx in a research report on Wednesday, March 2nd. Finally, Credit Suisse Group set a GBX 2,650 ($34.75) price target on Relx in a report on Tuesday, March 29th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of GBX 2,440.42 ($32.01).
Shares of Relx stock traded down GBX 10 ($0.13) during trading on Monday, hitting GBX 2,434 ($31.92). 2,444,855 shares of the company were exchanged, compared to its average volume of 3,187,357. The company has a quick ratio of 0.47, a current ratio of 0.63 and a debt-to-equity ratio of 191.50. Relx has a fifty-two week low of GBX 1,781 ($23.36) and a fifty-two week high of GBX 2,474 ($32.45). The stock has a market capitalization of £46.99 billion and a price-to-earnings ratio of 32.11. The firm has a 50 day moving average price of GBX 2,283.04 and a 200 day moving average price of GBX 2,283.66.
Relx Company Profile (Get Rating)
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare.
- 3 Undervalued Stocks The Insiders Are Buying
- The Market For Gamestop Is Near A Turning Point
- PayPal Stock is Still Ready for Bargain Hunting
- It’s Personal: 3 Personal Care Stocks to Own in Volatile Markets
- Conagra Stock Has More Room to Grow
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.